ChemBriefEli Lilly, Resilience to Invest $750 Million in US Drug Manufacturing Expansion
Eli Lilly and Resilience plan to invest $750 million to expand U.S. pharmaceutical manufacturing capacity, strengthening the domestic medicine supply chain and creating 400 jobs. The partnership will
reuters · 2026-07-30 05:58